140 related articles for article (PubMed ID: 15316939)
1. No evidence of the involvement of the Fas -670 promoter polymorphism in cervical cancer in situ.
Engelmark MT; Renkema KY; Gyllensten UB
Int J Cancer; 2004 Dec; 112(6):1084-5. PubMed ID: 15316939
[No Abstract] [Full Text] [Related]
2. Fas gene promoter -670 polymorphism (A/G) is associated with cervical carcinogenesis.
Ueda M; Hung YC; Terai Y; Yamaguchi H; Saito J; Nunobiki O; Noda S; Ueki M
Gynecol Oncol; 2005 Jul; 98(1):129-33. PubMed ID: 15894356
[TBL] [Abstract][Full Text] [Related]
3. Single nucleotide polymorphism at Fas promoter is associated with cervical carcinogenesis.
Lai HC; Sytwu HK; Sun CA; Yu MH; Yu CP; Liu HS; Chang CC; Chu TY
Int J Cancer; 2003 Jan; 103(2):221-5. PubMed ID: 12455036
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-10 -1082 gene polymorphism and susceptibility to cervical cancer among Japanese women.
Matsumoto K; Oki A; Satoh T; Okada S; Minaguchi T; Onuki M; Ochi H; Nakao S; Sakurai M; Abe A; Hamada H; Yoshikawa H
Jpn J Clin Oncol; 2010 Nov; 40(11):1113-6. PubMed ID: 20558465
[TBL] [Abstract][Full Text] [Related]
5. Glutathione-S-transferase and p53 polymorphisms in cervical carcinogenesis.
Ueda M; Hung YC; Terai Y; Saito J; Nunobiki O; Noda S; Ueki M
Gynecol Oncol; 2005 Mar; 96(3):736-40. PubMed ID: 15721419
[TBL] [Abstract][Full Text] [Related]
6. Association between p21 Ser31Arg polymorphism and the development of cervical lesion in women infected with high risk HPV.
Lima G; Santos E; Angelo H; Oliveira M; Heráclio S; Leite F; de Melo C; Crovella S; Maia M; Souza P
Tumour Biol; 2016 Aug; 37(8):10935-41. PubMed ID: 26886286
[TBL] [Abstract][Full Text] [Related]
7. Cervical cancer risk: is there a genetic component?
Magnusson PK; Gyllensten UB
Mol Med Today; 2000 Apr; 6(4):145-8. PubMed ID: 10740252
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus is not associated with breast carcinoma.
Yavuzer D; Salepci T; Karadayi N; Baloglu H; Kucukodaci Z
Breast Cancer Res Treat; 2010 Aug; 122(3):899-900. PubMed ID: 20521097
[No Abstract] [Full Text] [Related]
9. Highly differentiated keratinizing squamous cell cancer of the cervix.
Rubinstein E
Am J Surg Pathol; 2002 May; 26(5):676; author reply 676. PubMed ID: 11979099
[No Abstract] [Full Text] [Related]
10. Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix.
Yamashita T; Yaginuma Y; Saitoh Y; Kawai K; Kurakane T; Hayashi H; Ishikawa M
Carcinogenesis; 1999 Sep; 20(9):1733-6. PubMed ID: 10469618
[TBL] [Abstract][Full Text] [Related]
11. CCR2-V64I polymorphism is associated with increased risk of cervical cancer but not with HPV infection or pre-cancerous lesions in African women.
Chatterjee K; Dandara C; Hoffman M; Williamson AL
BMC Cancer; 2010 Jun; 10():278. PubMed ID: 20537184
[TBL] [Abstract][Full Text] [Related]
12. MDM2 SNP 309 human papillomavirus infection in cervical carcinogenesis.
Nunobiki O; Ueda M; Yamamoto M; Toji E; Sato N; Izuma S; Okamoto Y; Torii K; Noda S
Gynecol Oncol; 2010 Sep; 118(3):258-61. PubMed ID: 20538323
[TBL] [Abstract][Full Text] [Related]
13. Distribution of human papillomavirus genotypes in the patients with cervical carcinoma and its precursors in Zhejiang Province, China.
Hong D; Ye F; Chen H; Lü W; Cheng Q; Hu Y; Xie X
Int J Gynecol Cancer; 2008; 18(1):104-9. PubMed ID: 17466048
[TBL] [Abstract][Full Text] [Related]
14. Influence of IL-6, IL-8, and TGF-β1 gene polymorphisms on the risk of human papillomavirus-infection in women from Pernambuco, Brazil.
Lima SF; Tavares MM; Macedo JL; Oliveira RS; Heráclio SA; Maia MM; Souza PR; Moura R; Crovella S
Mem Inst Oswaldo Cruz; 2016 Nov; 111(11):663-669. PubMed ID: 27783717
[TBL] [Abstract][Full Text] [Related]
15. The role of human papillomavirus type 16 and the fragile histidine triad gene in the outcome of cervical neoplastic lesions.
Terry G; Ho L; Londesborough P; Cross P; Lopes A; Monaghan J; Cuzick J
Br J Cancer; 2004 Dec; 91(12):2056-62. PubMed ID: 15570308
[TBL] [Abstract][Full Text] [Related]
16. Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer.
Liu H; Liu S; Wang H; Xie X; Chen X; Zhang X; Zhang Y
Diagn Pathol; 2012 Oct; 7():147. PubMed ID: 23107094
[TBL] [Abstract][Full Text] [Related]
17. Case-control study of HLA-G promoter methylation status, HPV infection and cervical neoplasia in Curitiba, Brazil: a pilot analysis.
Gillio-Tos A; Bicalho Mda G; Fiano V; Grasso C; Tarallo V; De Marco L; Trevisan M; Xavier M; Slowik R; Carvalho NS; Maestri CA; Lacerda HM; Zugna D; Richiardi L; Merletti F
BMC Cancer; 2012 Dec; 12():618. PubMed ID: 23265140
[TBL] [Abstract][Full Text] [Related]
18. Analysis of 4 single-nucleotide polymorphisms in relation to cervical dysplasia and cancer development using a high-throughput ligation-detection reaction procedure.
von Keyserling H; Bergmann T; Schuetz M; Schiller U; Stanke J; Hoffmann C; Schneider A; Lehrach H; Dahl A; Kaufmann AM
Int J Gynecol Cancer; 2011 Dec; 21(9):1664-71. PubMed ID: 21897271
[TBL] [Abstract][Full Text] [Related]
19. TNFalpha polymorphism frequencies in HPV-associated cervical dysplasia.
Kirkpatrick A; Bidwell J; van den Brule AJ; Meijer CJ; Pawade J; Glew S
Gynecol Oncol; 2004 Feb; 92(2):675-9. PubMed ID: 14766265
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor (TNF) alpha and interleukin (IL) 18 genes polymorphisms are correlated with susceptibility to HPV infection in patients with and without cervical intraepithelial lesion.
Tavares MC; de Lima Júnior SF; Coelho AV; Marques TR; de Araújo DH; Heráclio Sde A; Amorim MM; de Souza PR; Crovella S
Ann Hum Biol; 2016 May; 43(3):261-8. PubMed ID: 26079218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
